Repairing Cream

string(95) "/home/virtual/"

Avene Xeracalm A.D Balsamo Relipidizante 200 ml


Skin with intense dryness, skin with atopic tendency, skins subject to itching.
Relipidizing Balm nourishes the skin with intense dryness and soothes the itching sensations of the baby, child and adult.

More details

By buying this product you can collect up to 1 loyalty point. Your cart will total 1 point that can be converted into a voucher of 0,20 €.

More info

Your Benefits

The relipidizing balm XeraCalm A.D is based on a formula made from a multi-competent biotechnological asset: I-modulia ®

• Imodulia ®: after 12 years of research Pierre Fabre, develops a biotechnological innovation that decreases itching, decreases inflammation and irritations due to hyperreactivity of the skin and fights bacterial overinfection by stimulating the innate immunity.
• CER-OMEGAS: repair/nut the skin and restore the epidermal barrier.
• The thermal water of Avene: soothing, anti-inflammatory and desensitizing.

The skin is calm, nourished and comfortable. The skin "doesn't itch anymore."

*Registered patent

Is it right for me?

XeraCalm A.D's relipidizing balm is specifically formulated for skin with severe dryness of the baby, child and adult:

• Skins with atopic tendency
• Itchy skins, itching due to skin dryness.
• Dry skin by nature

Formulated according to the regulations of sterile cosmetics: without perfume, without parabens and made with selected assets for their effectiveness and their safety.

The Proper Gesture

Apply the relipidizing balm XeraCalm A.D, 1 - 2 times a day to the dry areas of the face/body, previously clean with the Xeracalm A.D. Resticing Cleansing Oil.
After use, remove the excess from the product stopper and close.


patented 200 ml D.E.F.I tube

s other products in the same category:

Avene Xeracalm A.D Balsamo Relipidizante 200 ml

16,13 €

(8,07 € / 100 ML)




We use our own and third-party cookies to improve the browsing experience, and offer content and advertising of interest. By continuing browsing we understand that our cookie policy is accepted.

More information